Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001008310-07-000008
Filing Date
2007-05-03
Accepted
2007-05-03 16:45:08
Documents
1
Period of Report
2007-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5852
  Complete submission text file 0001008310-07-000008.txt   7598
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 8015843600
MELDRUM PETER D (Reporting) CIK: 0001008310 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 07816090